logo-horizontal-main.png
Oncocyte to Announce First Quarter 2024 Financial Results
13 mai 2024 08h00 HE | OncoCyte Corporation
Oncocyte to Announce First Quarter 2024 Financial Results
logo-horizontal-main.png
Oncocyte Reports Full Year 2023 Financial Results
12 avr. 2024 06h00 HE | OncoCyte Corporation
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS
logo-horizontal-main.png
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
11 avr. 2024 21h46 HE | OncoCyte Corporation
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
logo-horizontal-main.png
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
11 avr. 2024 17h30 HE | OncoCyte Corporation
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
logo-horizontal-main.png
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
09 avr. 2024 16h05 HE | OncoCyte Corporation
ONCOCYTE TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
logo-horizontal-main.png
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico
16 janv. 2024 08h00 HE | OncoCyte Corporation
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico
logo-horizontal-main.png
Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays
06 déc. 2023 08h00 HE | OncoCyte Corporation
- Significant unmet need for regulated product in $2B US testing market - Opportunity for expedited pathway for kitted product in development IRVINE, Calif., Dec. 06, 2023 (GLOBE NEWSWIRE) --...
logo-horizontal-main.png
Oncocyte Reports Third Quarter 2023 Financial Results
09 nov. 2023 07h00 HE | OncoCyte Corporation
-Launching First Products in 1H 2024- -Conference Call on Thursday, November 9, 2023 at 5:00 a.m. PT / 8:00 a.m. ET- IRVINE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq:...
logo-horizontal-main.png
Oncocyte to Announce Third Quarter 2023 Financial Results
03 nov. 2023 08h30 HE | OncoCyte Corporation
IRVINE, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that the company will host a conference call and webcast on...
Oncocyte_Logo_Horizontal_Main.jpg
VitaGraft Kidney Expands Utility in Recurrent Primary Disease Patients
25 juil. 2023 09h08 HE | Oncocyte Corporation
- Blood-based test differentiates between ABMR and IgAN, enabling faster and more effective treatment- Improved utility over standard of care tests- Paper published in peer-reviewed journal IRVINE,...